Korean Market
OWNR
HLB bioStep
★

HLB bioStep CEO Baek Seongjin Increases Stake to 0.06% via Open Market Purchase… Small but Positive Signal of Management Confidence

 
EXCH
HLB bioStep
★★

Notice of Unfaithful Disclosure Designation due to Revocation of New Facility Investment... Regulatory Risks and Potential Delisting Review

 
OWNR
HLB bioStep
★

HLB bioStep Non-Registered Director Myungjin Kim Reduces Stake from 0.34% to 0.10% via Open-Market Sales... Limited Impact on Share Price

 
EXCH
HLB bioStep
★

HLB BioStep Lifting of Trading Halt (Stock Split Listing Change)

 
PERI
HLB bioStep
★

HLB BioStep Q1 2026: Revenue Slightly Down, Net Loss Widens; Order Backlog of 24.6B Won

 
OWNR
HLB bioStep
★

Large Shareholding Report Form Submitted (No Specifics)

 
OWNR
HLB bioStep
★

HLB Executive & Major Shareholder Ownership Unchanged - Routine Filing

 
OWNR
HLB bioStep
★

Submission of Ownership Report for Specific Securities by Executives/Major Shareholders (No Content)

 
OWNR
HLB bioStep
★

Report on Holdings of Specific Securities by Executives and Major Shareholders (No Data Filed)

 
OWNR
HLB bioStep
★

Report on Ownership of Specific Securities by Executives and Major Shareholders (Blank Template)

 
OWNR
HLB bioStep
★

Executive and Major Shareholder Securities Ownership Report (No Data)

 
OWNR
HLB bioStep
★

Insider Ownership Report Filed (No Changes)

 
OWNR
HLB bioStep
★

Report on Ownership of Specific Securities by Executives and Major Shareholders (No Changes)

 
OWNR
HLB bioStep
★

Submission of Report on Ownership of Specific Securities by Executives and Major Shareholders (No Change)

 
OWNR
HLB bioStep
★

Submission of Ownership Report on Specific Securities by Executives and Major Shareholders (No Changes)